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Abstract 
Cancer is a disease of uncontrolled cell growth and abnormal cell proliferation. 
There are a myriad of genetic modifications that disrupt proper cell functioning and can 
lead to cancer, and recent studies have suggested that improper chromatin remodeling 
may be yet another mechanism that leads to uncontrolled cell proliferation. 
Chromo domain helicase DNA binding proteins (CHD) are a family of proteins that have 
been associated with chromatin regulation and as a result, genome transcription 
regulation. Studies on the CHD family could have implications in cancer research 
because of the proteins' role in chromatin remodeling, gene expression and possibly 
chromosomal stability. 
Research in our laboratory focuses on the Chromodomain helicase binding 2 
protein (CHD2). Previously, the lab developed a CHD2 deficient mouse model which is 
characterized by a high susceptibility for lymphomas. The goal of this research project 
was to analyze the molecular mechanisms of Chd2 deficiency induced lymphomas and 
determine if the Chd2 protein is a substrate for A TM kinase, a well known DNA damage 
signaling kinase. To this end, an HA-tagged version of Chd2 was transfected into human 
cancer cell lines and exposed to DNA-damaging stimulus. Analysis of the Chd2 peptides 
for ATM specific phosphorylation indicated that the results so far were inconclusive. 
Additional experiments to unequivocally determine the phosphorylation of Chd2 by 
ATM are currently being planned and discussed. 
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Introduction 
Cancer is a disease of uninhibited cell growth and atypical cell proliferation. The 
stability of the genome, the fidelity of its replication, and the efficiency of DNA 
replication are crucial to normal cell growth and development. The genetic material is 
manipulated several times throughout the cell's lifecycle, greatly increasing the chances 
of incorporating mistakes and developing DNA damage. The enormously lengthy 
genome must be packaged in order to fit within the nucleus of the cell. In the initial step 
of the DNA condensing process, the naked double-stranded DNA is wound around an 
octamer of basic histone proteins, producing a nucleosome. The nucleosome consists of 
a core of five types of his tones, HI, H2A, H2B, H3, and H4, and DNA wrapped about 1.8 
times around the core [1]. Each nucleosome occurs at regular intervals along a DNA 
strand, resulting in a "beads on a string" formation. Further winding and looping results 
in a chromatin fiber and higher level structures, ultimately forming the characteristically 
compact chromosome form which can easily fit within the confines of the cell's nucleus. 
The later steps are dependent on a correctly executed nucleosome configuration; 
however, by intentionally changing the charge on histones, the cell can render genes 
active, inactive, or responsive to developmental and external signals [2]. 
The reverse of this compaction process is equally important. Transcription 
repression is caused by packaging promoters within nucleosomes, which prevents 
initiation. It is therefore, very important to unpack DNA to give RNA polymerases and 
other related proteins access to the genetic material. This allows for genomic 
transcription and elongation, and further downstream, protein formation. In order to 
counteract the condensing activity of nucleosomes and free the promoter regions, cells 
'r 
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have chromatin-remodeling complexes which can disrupt DNA-histone interactions by 
clearing a portion ofnucleosome-free DNA in an ATP-dependent manner. Initiation of 
transcription by chromatin remodeling can occur through a variety of mechanisms 
including destabilizing the nucleosome itself (SWIISNF -related complexes), transferring 
histones octamers to a separate DNA molecule (RSC, a member of the SWI/SNF family), 
and "sliding" histones to different areas along the same strand of DNA (lSWI complexes) 
[3]. Elongation, in contrast, can occur regardless ofnucleosomes. RNA polymerase 
(pol) II can continue to transcribe while the cell maintains the nucleosome structure by 
recruiting a number of elongation, chromatin-related, and chromatin-remodeling factors 
to the site of elongation [3, 4]. 
In addition to its role in transcription and elongation, chromatin-remodeling plays 
a role in other chromatin-based processes including, recombination, regulation of gene 
expression, and double-strand DNA (dsDNA) repair response. Chromatin remodeling 
complexes such as the well-studied SWI-SNF family assist in dsDNA break repair more 
specifically through the homologous recombination pathway. The ATP-dependent 
complexes, SWI-SNF and RSC, hydrolyze histones or rearrange nucleosomes, allowing 
greater accessibility of regulatory proteins to the undamaged sister chromosome's DNA 
[5]. By exposing the homologous donor sequence, the chromatin-remodeling complexes 
allow homology-searching complexes to work. Defects in chromatin-remodeling 
complexes show poor cellular response to DNA double strand breaks, resulting in an 
accumulation of genomic alterations and the potential for cancer development. The well­
characterized SWIISNF family has been long defined as a chromatin remodeler. The 
lesser known, poorly-studied chromo domain helicase DNA-binding (Chd) family has just 
" 
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recently demonstrated its importance in transcription regulation and developmental 
processes [11]. 
The Chd family 
The Chromodomain helicase DNA binding (Chd) family of genes encode a group 
of ATP-dependent chromatin remodeling proteins. They are part of the SNF2 
superfamily ofproteins. All members of the Chd family are distinguished by two 
sequence motifs: tandem chromo domains (Chromatin organization modifier) and SNF2­
like ATPase domains. Chd proteins are activated by single-stranded, double-stranded, or 
nucleosomal DNA and exert their effects on transcriptional activation by aiding in 
chromatin remodeling. Because the Chd proteins render chromatin into transcriptionally 
inactive heterochromatic form, it is suggested that Chd could playa role in gene 
expression as a negative regulator [7]. 
The chromodomain is a 50 amino acid region. The evolutionarily conserved 
sequence is found to have a role in chromatin-structure remodeling in an ATP-dependent 
manner and transcriptional regulation of genes. Chromodomains are characteristically 
found in proteins that can interact with heterochromatin such as heterochromatin protein 
1 (RPl) and polycomb (Pc) proteins [8]. Importantly, the chromo domain and helicase 
domains have been found to be necessary for appropriate interaction with chromatin. 
This association is mediated by the chromodomain, which binds the protein directly to 
RNA, DNA, and methylated R3 histone [6]. Other functions of Chd family members 
include association with transcriptional repression. In general, Chd family proteins playa 
crucial role in chromatin-related processes, particularly gene expression. 
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The Chd family is further broken down into three subfamilies: The Chdl-Chd2 
family, the Chd3-Chd4 family, and the Chd5-Chd9 family. Each subfamily has its own 
identifying structures, domains, and functions. Briefly, the Chdl-Chd2 proteins contain a 
229 amino acid region near the C-terminus used as a DNA-binding domain which 
preferentially binds to AT-rich DNA sequences. The Chd3-Chd4 family most notably 
lacks the DNA-binding domain. Instead, the proteins have two N-terminal plan homeo 
domains (PHD) which resembles Zn-finger domains. The subfamily consisting of Chd5­
Chd9 has extra domains, including paired Brahma and Kismet (BRK) domains, switch­
defective protein 3, adaptor 2, nuclear receptor co-repressor transcription factor IIIB 
(SANT-like) domain, CR domains, and a DNA-binding domain. As with the Chdl-Chd2 
family, Chd5-Chd9's DNA-binding domain shows a preference for AT-rich DNA 
portions [6]. 
Of the Chd family of proteins, Chdl is one of the better characterized. Both 
mouse Chdl (MmCHDI) and human Chdl (HsCHD1) have a pair of chromodomains, a 
single helicase/ A TPase domain, and a DNA-binding domain. Chd l' s biggest role seems 
to be in interacting between transcribed genes and transcription elongation factors, as 
evidenced by its physical interactions with RNA elongation complexes PAF, FACT, and 
Spt4/5 [9]. In humans, it has been shown that PAF, FACT, and associated ubiquitylation 
factors move onto the transcribed regions. Subsequent monouibiquitylation of H2B leads 
to trimethylation ofH3K4 which is theorized to recruit Chdl [9]. Recent data has shown 
that Chdl may playa crucial role in transcription termination with RNA pol II because of 
its localization to 3'-untranslated regions of genes [10]. Finally, Chdl is speculated to 
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have a potential role in replication because of its association with Spt16 and Pob3, which 
may be involved in replication [10]. 
The other member of the first subfamily, Chd2, is closely related to Chdl. Chd1 
and Chd2 share a high homology between chromo domain motifs (77. 9% similarity) and 
helicase/ATPase domains (92.3% similarity); however, their greatest differences are in 
the DNA-binding domain (75.1 % similarity) [10]. Chd2 has several distinctive structural 
motifs: several bipartite nuclear localization signals (NLS-BP), a Myb-DNA binding 
domain, a centrally located helicasel ATPase domain, paired chromodomains near the N 
terminus, and an A+T hook. The Myb-DNA binding domain is a DNA binding domain 
(DBD) unique for its consensus sequence and the two-fold manner in which it binds 
protein and DNA, through contact with either the sugar phosphate backbone or the base 
itself [11]. This Myb-related DBD has been suggested to playa role in cell 
differentiation and proliferation [12]. The helicase/ATPase domain putatively allows 
efficient Chd functioning by altering DNA-protein interactions and unwinding DNA [7]. 
The A+T hook allows for preferential Chd binding to A-T rich sequences of DNA [7]. 
The chromo domain, chromatin organization modifier, is a 50 amino acid motif with roles 
in chromatin remodeling and transcriptional gene regulation [6]. 
I Bipa rtit.e Nuclear Myb-DNA Binding Domain L o c a lizat:i o n Signa l 
_ Helica seC 
Chro rnooo n'la in 
... A+THook 
Figure 1. Schematic diagram of the Chd2 protein structure representing various domains. 
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Putative functions of Chd2 include a role in development and differentiation 
through cell-cycle progression [13]. Data shows that Chd2 deficient heterozygous mouse 
models survived past perinatal stages, but sustained multiple organ anomalies [13]. Chd2 
deficient homozygous mouse models did not survive either because of embryonic 
lethality or post-birth infanticide [13]. Research into Chd2 and its functions is still in its 
infancy. Not much is known about the protein, but due to the Chd family's role in 
chromatin regulation, it is suggested that Chd2 may have a role in cancer prevention 
because of its role in chromosomal stability. 
Ataxia telangiectasia mutated protein (A TM) 
Ataxia telangiectasia mutated (ATM) is a protein kinase that is integral in several 
double strand DNA (dsDNA) breaks. ATM coordinates a series of complicated, multi­
passage system ofpathways that react to dsDNA breaks. These pathways then 
momentarily halt the cell cycle and organize to repair the DNA damage. Named for the 
mutated gene in the human disorder ataxia telangiectasia (AT), ataxia telangiectasia 
mutated (ATM) is part of a protein family that has kinase activity at serine/threonine 
motifs [14]. ATM is a 3056 amino acid protein with sequential FAT domain, PI(3)K 
domain, and FATC domain at the carboxy-terminus [15]. The FAT and FATC domain 
functions have not yet been clearly elucidated. The PI(3)K domain is named for its 
homology with phosphotidylinositol-3-0H-kinases' catalytic sequences and contains the 
motifs for the catalytic site of the protein [16]. 
A TM and related protein A TR, when activated, have the potential to bring about 
G 1 arrest, G2 arrest, cell repair, and/or activate stress response genes. Through 
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phosphorylation of substrates such as Brca1, NBS1, p53, Chk1l2, and Mdm2, ATM can 
help promote cell genome stability [16, 17]. 
ATM is primarily activated by double strand DNA breaks caused by IR. Because 
ofATM's impressively quick response to DNA breaks, the mechanism for ATM 
activation has been highly contended. It has yet to be determined whether A TM is 
directly activated by DNA damage and physical contact with the break or indirectly 
activated through chromatin alteration. Research has shown that A TM may 
autophosphorylate a dimeric inactive form of itself. Constitutively, ATM is proposed to 
exist in some form of multimer, held in check by the FAT domain. Post DNA damage, 
A TM responds by phosphorylating the other units in the FAT domain, freeing all units 
involved. The ATM protein can then become active as a monomer [16]. 
ATM plays an important role in genome protection and genomic stability. The 
best-studied ATM activity is the response to double strand DNA breaks. The almost 
immediate response is effective because of ATM' s activation strategies. A TM stimulates 
its many substrates through several different mechanisms, ensuring activation of the 
necessary downstream targets. This is demonstrated by p53, a defined tumor repressor 
and ATM substrate. ATM can directly phosphorylate p53, phosphorylate CHK2, which 
in tum phosphorylates p53, or phosphorylate MDM2, which leads to the degradation of 
p53. These changes in p53 arbitrate the G 1-S stage of the cell cycle. ATM also adopts 
an "all roads lead to Rome" strategy in which it works from different pathways to a 
common end point. The S-G2 cell cycle checkpoint is controlled by A TM through 
several different pathways; the BRCA 1, CHK2, and SMC 1 substrates all activate 
separate paths that have the common end ofhalting the cell cycle at the S phase. Finally, 
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ATM utilizes a "domino effect" which can activate substrates into kinases themselves. 
The resulting kinases can phosphorylate downstream targets, increasing the efficiency 
with which A TM responds to DNA damage [16]. 
Some notable ATM substrates and pathways include p53, CHK1/2, SMC1, 
BRCA1, NBS 1, and MDM2. All pathways result in some form of cell cycle control at 
various checkpoints. Cell cycle checkpoints are important in normal replication and cell 
growth. In response to abnormal signals, checkpoints can temporarily halt the cell cycle 
or signal cell death. There is redundancy within the pathway intermediates and 
endpoints, demonstrating ATM's efficiency at responding to DNA strand breaks [17]. 
A TM also has other potential mechanisms by which it protects a celL A TM has been 
suggested to participate in cell cycle checkpoint activation and may playa role in 
preserving telomeres, the protective genome sequence at chromosome ends [16]. 
Because of ATM's integral role in genomic stability, there is strong link between ATM 
mutations and cancer. 
Rationale 
ATM is known to phosphorylate serine/threonine (S/Q) motifs. Research has 
shown that in order for phosphorylation to occur, hydrophobic amino acids must be 
present at N-I and N-3 positions [11]. Analysis of the mouse Chd2 amino acid sequence 
revealed ten S/Q motifs as potential ATM phosphorylation sites. Further analysis of the 
S/Q motif sequences showed five out of the ten possible phosphorylation sites had a 
hydrophobic amino acid at either the N-I or N-3 positions, and only one out often had 
both. The central hypothesis of this project is that Chd2 is an A TM substrate and 
functions at the chromatin level to affect DNA damage responses including DNA damage 
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specific chromatin remodeling and repair. This is based on our previous work with the 
Chd2 mouse model that are susceptible to lymphomas and the Chd2 mutant cells that 
accumulate spontaneous DNA strand breaks. 
1 mmrnkdksqe edsslhsnas srsaseevsg sdsgsqsese qgsepgsghg sesnsssess 
61 esqseseses agsksqpvlp eakekpaskk eriadvkkmw eeypdvygvr rsnrsrqeps 
121 rfnvkgeass gsesgspkrr gqrqlkkqek wkqdpsedeq eqgtsaesea eqkkgkarrp 
181 vprrtvpkpq vkkqpkiqrg krkkqessdd dddddeapkr qtrrraaknv sykedddfet 
241 dsddliemtg eggdeqqdns etiekvldsr Igkkgatgas ttvyaveang dpsddfdter 
301 eegevqylik wkgwsyihst wesedslqqq kvkglkklen fkkkedevkq wlgkvspedv 
361 eyfscqqela selnkqyqiv erviavktsk stlgqtdfpa hsrkpapsne peylckwmgl 
421 pysecswede aligkkfqnc idsfhsrnns ktiptrecka Ikqrprfval kkqpaylgge 
481 slelrdyqle glnwlahswc ks(nsvilade mglgktiqti sflsylfhqh qlygpflivv 
541 plstltswqr efeiwapein vvvyigdims rntireyewi hsqtkrlkfn alittyeill 
601 kdktvlgsin waflgvdeah rlknddslly ktlidfksnh rllitgtp)lq nslkelwsll 
661 hfimpekfef wedfeedhgk grengyqslh kvlepfllrr vkkdvekslp akveqilrve 
721 msalqkqyyk wiltrnykal akgtrgstsg flnivmelkk ccnhcylika pedseresgq 
781 evlqslirss gklilldkll trlrergnrv lifsqmvrml dilaeyltik hypfqrldgs 
841 ikgeirkqal dhfnadgsed fcfllstrag glginlasad tvvifdsdwn pqndlqaqar 
901 ahrigqkkqv niyrlvtkgt veeeiierak kkmvldhlvi qrmdttgrtv lennsgrsns 
961 npfnkeelta ilkfgaedlf keiegeesep qemdideilr laetrenevs tsatdellsq 
1021 fkvanfatme deeeleerph kdwdeiipee qrkkveeeer qkeleeiyml prirsstkka 
1081 qtndsdsdte skrqaqrssa sesetddsdd dkkpkrrgrp rsvrkdlveg ftdaeirrfi 
1141 kaykkfglpl erleciarda elvdksvadl krlgelihns cvsamqeyee qlkestsegk 
1201 gpgkrrgpti kisgvqvnvk siiqheeefe mlhksipvdp eekkkycitc rvkaahfdve 
1261 wgveddsrlllgiyehgygn weliktdpel kltdkilpve tdkkpqgkql qtrvdyllkl 
1321 Irkglekkgt vasgeeaklk krkprvkken kaprlkdehg lepasprhsd npseegevkd 
1381 dgleksptkk kqkkkenken kekpvssrkd regdkerkks kdkkekvkgg dgkssskskr 
1441 sqgpvhitag sepvpigede dddldqetfs ickermrpvk kalkqldkpd kglsvqeqle 
1501 htrncllkig driaeclkay sdqehiklwr rnlwifvskf tefdarklhk Iykmahkkrs 
1561 qeeeeqkkkd dslggkkpfr peasgssrds lisqshtshn Ihpqkphlpa shgpqmhghp 
1621 rdnyshpnkr hfsnadrgdw qrerkfnygg gnsapwggdr hhqyeqhwyk dhhygdrrhm 
1681 dahrsgsyrp nnmsrkrpye qynsdrdhrg hrdyydrhhh dskrrrsddf rpqnyhqqdf 
1741 rrmsdhrptm gyhgqgpsdh yrsfhtdklg eykqpmpslh talsdprspp sqksphdsks 
1801 pldhrspler sleqknnpdy nwnvrkt 
Figure 2. The mouse Chd2 amino acid sequence. The ten SQ motifs are shown in bold. 
The mouse Chd2 peptide sequence was obtained from the Ensemble database (version m36). 
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Materials and Methods 
Sequence analysis 
Computational analysis of the mouse Chd2 protein sequence was performed to 
establish the number of SQ-potential phosphorylation sites, locate the SQ sites, and 
evaluate the amino acids in the N-1 and N-3 positions. Calculations were then made to 
determine which sites were most viable to ATM phosphorylation. 
Cloning of murine Chd2 gene segments 
Previous work in the lab created a nearly full length, 1395 amino acid Chd2 clone 
containing an HA (hemaglutanin) tag. To create this clone, a series three of 
commercially available (Open Biosystems) cDNA clones that were homologous to the 
Chd2 protein were used. It was found through a blast comparison that mouse Chd2 and 
human Chd2 had 94% homology, so mouse Chd2 was used. The first clone, M2021 in a 
PT7T3D-Pacl vector, contained the base pairs for the first 140 amino acids. Clone 2, 
named M5007, was in a pSport6 mammalian vector and contained 1143.3 amino acids 
after the M2021 clone. There was an 80 base pair overlap between the end of M2021 and 
the start of M5007. Restriction sites were added in order to cleave the clones at 
appropriate sequences. M2021 clone was introduced into the pSport6 vector through 
cloning and digestion with enzymes Xho 1 and Not 1. The M5007 clone was cut with SaIl 
and Not1 and the two cut clones, M2021 and M5007, were ligated together to form 
temporarily named clone PChd3KJ. 
C-terminal HA-tagging of 1395 aa of Chd2 
To create the HA-tagged portion of the final clone, the last of the three 
commercial cDNA clones, M6213, was used. Forward primer 5007EF began by 
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overlapping part of the M5007 region and the CTHAX reverse primer coded for an HA­

tag and Xba1 restriction site. The resulting product contained a portion of Chd2, an HA­

tag, and an Xba1 site. This, and the previously created PChd3KJ were cut with Xba1 and 

ligated together within the pSport6 vector. The final clone PChdKHA(CT) was finished. 

It consists of part M2021, part M5007, and part M6213, and codes for two 

chromo domains, the helicasel ATPase domain, and several bipartite nuclear localization 





Two 2-well chamber slides were seeded with 25,000 U20S cells per chamber. 
Immunofluorescence was done after transfection with the PChdKHA(CT) clone to 
confirm localization of the clone to the nucleus. Briefly, the chamber slides were fixed in 
acetone: methanol, rinsed with Tris buffered saline, then incubated with antibody dilution 
buffer (3%BSA, 10% goat serum, 0.05% Triton X-100 in PBS pH 7.4) ADB, for an hour. 
Primary antibody, mouse anti-HA (1: 1 000 in ADB) was applied for 4 hours in a humidity 
chamber at room temperature. After 3 x 2ml/10min washes of working ADB, secondary 
antibody was added. Fluoroisothiocyanate (FITC) conjugated goat a-mouse (1 :250 in 
ADB) was incubated in the humidity chamber for 1 hour at room temperature. The 
chamber walls were removed and each slide was washed with PBS-Photoflo (0.2%), 
PBS-Triton (0.05%), and PBS-Photoflo (0.2%) for 10 minutes each. The DNA was 
stained with DAPI (4',6-diamidino-2-phenylindole), and after completely removing the 
final stain, each slide was sealed with a cover-slip. Each slide was viewed using 
immunofluorescence microscopy. 
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A western blot was also performed to confirm the success of the transfection. 
Celllysates were prepared with cold lysis buffer containing protease and phosphotase 
inhibitors, then sonicated. The lysates were loaded into a 5.5% SDS-PAGE mini-gel. 
Post-electrophoresis, the gel was transferred onto a 0.45flm PVDF membrane overnight. 
The membrane was blocked in 5% blotto for several hours, then rinsed with three 
appropriate volumes of TBS/Tween at 5 minutes each, at room temperature. The primary 
antibody, mouse a-HA (1 :1000 in 2% blotto), was added to the membrane for 2 hours at 
room temperature. The membrane was then washed with TBS/Tween for 10 minutes, 
followed by another 10 minutes in 2% blotto, and a final 10 minute wash in TBS/Tween. 
The secondary antibody, a-mouse HRP (1 :2000 in 2% blotto), was applied for 1 hour at 
room temperature. The membrane was then rinsed three times in TBS/Tween for 20 
minutes each. 2 ml of SuperSignal West Pico Chemiluminescent Substrate (Pierce) was 
added to the membrane for 3 minutes. The film was developed after a 5 minute exposure. 
Expression and phosphorylation of Chd2: 
293T cells were plated in antibiotic free media and cultured overnight. 
Transfection was performed using the Lipofectamine kit according to amufacturer's 
suggestions (Invitrogen). Fresh media was added 4 hours and cells were treated with 
different DNA damaging agents after 48 hrs of post-transfection and incubated for 
specific times as shown in table 1. 
1 2 3 4 5 6 7 
U ntransfected X-ray X-ray 0.1% MMS 0.1% MMS UV UV 
arid untreated 50j 50j 30 min 2 hr 40gy 40gy 
control 30 min 2 hr 30 min 2 hr 
Table 1. DNA damage treatment scheme. Table shows the plate and specific treatment of 
the cells expressing Ha-tagged Chd2 peptides. 
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After treatment, cells were collected, washed in media, and resuspended in cold 
lysis buffer (l50mM NaCI + 50mM Tris pH 8) containing protease and phosphotase 
inhibitors. The lysates were then subjected to sonication to shear the DNA. After the 
shearing step, 250 J.!l of cell lysate was incubated with 1 ~ll DNase and 2.5 J.!IIM MgS04 
and rocked at room temperature for 30 minutes. 250 J.!l NET gel buffer with 2mM EDT A 
and 20 J.!l of HA beads was added. The complex was rocked at 4°C overnight. The 
following day, after a short centrifugation, the bead-protein complex was washed 3 times 
with 500 J.!l cold NET gel buffer containing protease inhibitor/phosphotase inhibitor each 
time. To the pellet, IX SDS loading buffer was added and samples were boiled at 95°C 
for 3 minutes, and loaded onto a 5.5% SDS-PAGE mini-gel. After electrophoresis, the 
gel was transferred onto a 0.45 J.!m PVDF membrane and blocked for several hours, then 
rinsed with three 5 minute washes ofTBS/Tween at room temperature. 
Western blots were perfonned with antibodies specific for a-ATM/ ATR 
phosphorylated SQ/ST antibody (1:1000 in 2% blotto overnight at 4°C) and secondary 
antibodies a-rabbit HRP (1 :2000 in 2% blotto, 1 hr at room temperature). The membrane 
was rinsed three times in TBS/Tween washes of 20 minutes each between incubations. 
SuperSignal West Pico Chemiluminescent Substrate was used to develop the membrane. 
The film was left for two exposures, at 30 minutes and 1 hour. After stripping the 
membrane with washing buffer (lXTBS + 0.5M NaCh + 0.2M SDS), the membrane was 
reblocked with 5% blotto. The subsequent western blot was perfonned using primary 
antibody a-HA (1:1000 in 2% blotto) incubated for 1.5 hours and secondary antibody a­




Computational analysis of Chd2 sequence for SQ motifs 
Computational analysis of the mouse Chd2 amino acid sequence showed a total of 
ten sq motifs. 5/1 0 SQ motifs had a hydrophobic amino acid at either the N-1 or N-3 
position; 1110 SQ motifs had a hydrophobic amino acid at the N-3; 3110 SQ motifs had a 
hydrophobic amino acid at the N-1 position; finally, only 1110 SQ motifs had the 
necessary hydrophobic amino acids at the N-1 and N-3 positions. (See Fig. 3). 














Figure 3. Comparison of ten prospective ATM phosphorylation site S/Q motifs. 
Each sequence includes the SQ motif, four preceding amino acids, and one following amino acid. 
Green highlights denote the N-I and N-3 positions; red highlights denote hydrophobic amino 
acids in the N-1 and/or N-3 position. 
Expression and nuclear localization of HA-Chd2 peptide 
To determine the expression levels and the sub cellular localization of the HA-
tagged Chd2 peptide, we performed western-blot and immuno-fluorescence assays. The 
western blots confirmed the optimal expression of the HA-tagged 1395 amino acid Chd2 
clone as shown in figure 4a. Immunofluorescence analysis demonstrated the localization 
of the PChdKHA(CT) clone within the nucleus of the transfected U20S cells. As shown 
in figure 4b, expression analysis ofHA-Chd2 using anti-HA antibodies indicated that the 
HA-Chd2 peptide was confined only to the nucleus. The overlapping of nuclear staining 
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with DAPI and HA-Chd2 signal with FITC conjugated secondary amino acids signified 
the localization of the expressed peptide to the nucleus (Figure 4b). This is consistent 
with the fact that the HA-tagged Chd2 peptide contains four bipartite nuclear signals 
within its sequence. 
a. b. 
Untransfected Transfected 
~b>~ J;;'--~- "!; '" -,,"I,. 
_~1!;:~" _­
Figure 4. Expression and subcellular localization ofHA-tagged Chd2. The representative 
western blot using a-HA antibody to demonstrate expression ofHA-tagged Chd2 into cells is 
shown in panel a. The fluorescently stained images on the left (panel b) show the nuclear staining 
by the DNA binding dye, DAPI. The right panel shows expression ofHA-tagged Chd2 that is 
visualized by FITC staining. 
ATM phosphorylation of HA-Chd2 
To determine, if the exogenously expressed HA-Chd2 peptide was 
phosphorylated after DNA damage, we performed immunoprecipitation analysis 
followed by immunoblot analysis with antibodies specific for phosphorylated SQ/ST 
motifs. The western blots with a-ATMIATR phosphorylated SQ/ST antibodies were 
inconclusive. The a-HA film showed expected bands for our HA-tagged 1395 amino 
acid Chd2 clone at ~160 Kd (figure 5). Importantly we did not detect any 
phosphorylated bands around 160 Kd indicating that the HA-tagged Chd2 peptide is not 
phosphorylated under the conditions that were analyzed. The a-ATMIATR 
phosphorylated SQ/ST blot, however, produced a non-specific band at a lower molecular 
weight (~ 130 kD) than the expected molecular weight ofHA-Chd2 peptide in all the 
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transfected and un-transfected samples. The presence of the novel band in the un­
transfected samples also suggested that the novel band may be a non-specific cellular 
protein bound by the anti-HA sepharose beads. 
Con. MMS UV X-ray 
UTr. Tr. O.5h 2h O.5h 2h O.5h 2h 
-160k '~I""I· ....-Chd2 (anti-HA) 
-130k Non-specific 
Peptide (anti-pSQ/ST) 
Figure 5. Analysis of SQ/ST phosphorylation patterns of HA-Chd2. Comparison of a­
HA and a-ATMIATR phosphorylated SQ/ST western blots is shown above. UTr., untransfected 
control; Tr., transfected untreated control. 
Discussion 
The Chd2 protein has 2 chromodomains and a helicasel A TPase domain, 
suggesting it has a role in chromatin remodeling, chromosomal stability, and DNA repair. 
Our lab previously created a knockout mouse model for Chd2 using gene trap 
technology. We found that mice heterozygous for Chd2 had a propensity to develop 
lymphomas, and nullizygous mutants suffered from neonatal lethality. Based on the 
previous observations, we hypothesized that Chd2 plays an important role in genomic 
stability maintenance. 
In an effort to determine the biochemical functions of Chd2 that relate to genome 
stability maintenance we sought to determine if Chd2 was a substrate of the DNA 
damage inducible kinase, ATM. Sequence analysis of the mouse Chd2 protein also 
suggested ten potential SQ motifs for ATM phosphorylation. To investigate whether 
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Chd2 is a potential substrate ofATM, a recombinant Chd2 peptide (1395 amino acid 
Chd2 tagged with HA) was created and expressed in 293T and U20S cells. HA-Chd2 
transfected human cancer cells were exposed to three DNA damage-causing agents. 
Expression and localization of the recombinant peptide into the nucleus was confirmed 
by western blot and immunofluorescence, respectively. 
The ATM phosphorylation experiment yielded unexpected results in that the 
bands from the anti-HA blot and the anti-ATM/ATR phosphorylated SQ/ST did not 
match. The HA blot expressed expected bands for HA-tagged Chd2 between 160 - 170 
kD. The a-ATMlATR phosphorylated SQ/ST blot revealed a lower molecular weight 
band. Even though the band does not represent Chd2, its mere presence indicates that 
something else within the cell is being phosphorylated by ATM or ATR, as the antibody 
is extremely specific to ATMIATR-phosphorylated SQ/ST motifs. It is unclear as to 
what this unknown ATM substrate could be because ATM has numerous substrates, 
some of which are still unidentified. The a-ATM/ATR phosphorylated SQ/ST blot also 
showed evidence of phosphorylation of the non-specific protein in the untransfected 
control, suggesting an SQ or ST motif may have acted upon by constitutive ATM 
phosphorylation activity without DNA damage. The 293T cell line was originally chosen 
for its fast growth, high transfection efficiency, and ease of manipulation; however, after 
further research, it was found that 293T cells may not be the best cells for use in ATM 
phosphorylation experiments. The 293T cells are human embryonic kidney cells 
transformed by a rare adenovirus integration event that alters E 1 A and B genes, among 
several others [18]. Further literature searches found that 293 cells are highly susceptible 
to a variety of virus transformants including herpes simplex virus, parainfluenza virus, 
Chi - 20 
and respiratory syncytial virus [19]. Furthermore, simian virus 40 (SV 40) affects A TM 
functioning and SV 40 expression can activate A TM and subsequently affect downstream 
A TM substrates and pathways [20]. These findings and our inconclusive results suggest 
that 293T is an unsuitable cell line for DNA damage response related studies. This is due 
to the fact that expression of SV 40 in 293 T cells makes it difficult to distinguish the 
differences between the effects of constitutive A TM activation by SV 40 and the 
experimental DNA-damaging treatments. 
Future Work 
There are several possible avenues for continuing with this work. As discussed, 
the ATM phosphorylation experiment with 293T cells was not successful. Currently, the 
ATM phosphorylation of Chd2 experiment is being repeated using U20S cells, which are 
better suited for the experiment. U20S cells are derived from bone tissue of an 
osteosarcoma patient [21]. They resemble epithelial cells and are free of adenoviruses, 
RSV, and most importantly, SV40, making them useful for DNA damage studies 
involving tumor suppressor genes [21]. Concurrently, our lab has developed a 1395 
amino acid Chd2 clone with Tandem affinity purification (TAP) tags containing histidine 
and strep tags. We plan to repeat the A TM experiment with TAP-tagged Chd2 in U20S 
cells. If the A TM phosphorylation experiments are successful, an in vitro kinase assay 
would be performed to determine whether Chd2 is phosphorylated by ATMIA TR. As a 
substrate, purified Chd2 will be used in conjunction with kinase obtained from U20S 
cells and AT deficient cell lines. The results of this experiment would help determine if 
• 
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Chd2 is indeed phosphorylated by ATM after DNA damage and provide mechanistic 
insights on the role of Chd2 in DNA damage response pathways. 
• 
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